Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular biology of esophageal cancer.

Chest surgery clinics of North America - 1 Aug 2000

D'Amico T A, Harpole D H

Abstract excerpt

Several mechanisms of resistance to chemotherapy have been identified among the agents that are commonly used in the systemic treatment of patients with esophageal cancer: paclitaxel, platinum, and 5-FU. A recent study from our laboratory evaluated the initial endoscopic biopsy material from patients who subsequently underwent trimodality therapy, including chemotherapy with cisplatin and 5-FU, radiation therapy,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Antineoplastic Agents, Phytogenic
Share to Barrett Esophagus

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Squamous Cell

Share to DNA Damage

Share to Esophageal Neoplasms

Share to Genes, p53

Share to Paclitaxel

Source

Identifiers

PMID: 10967750

Genes

EGF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular biology of esophageal cancer.PMID 10967750Read ↗

Molecular mechanisms associated with chemoresistance in esophageal cancer.Semantic proximity Read ↗

Molecular aspects of esophageal squamous cell carcinoma carcinogenesisSemantic proximity Read ↗

The molecular biology of esophageal and gastric cancer and their precursors: oncogenes, tumor suppressor genes, and growth factors.Semantic proximity Read ↗

The cell and molecular biology of esophageal carcinoma.Semantic proximity Read ↗

The involvement of MCTP1 in the drug-resistance of esophageal cancer cellsSemantic proximity Read ↗

Targeted therapy in esophageal cancer.Semantic proximity Read ↗

Platinum Resistance: The Role of DNA Repair PathwaysSemantic proximity Read ↗

Epidermal growth factor receptor, p53 mutation, and pathological response predict survival in patients with locally advanced esophageal cancer treated with preoperative chemoradiotherapy.Semantic proximity Read ↗

MicroRNA signatures in chemotherapy resistant esophageal cancer cell linesSemantic proximity Read ↗

Carcinogenesis and genetic alterations in squamous epithelium of the esophagus.Semantic proximity Read ↗

p53 Mutation status predicts pathological response to chemoradiotherapy in locally advanced esophageal cancer.Semantic proximity Read ↗

XPD inhibits cell growth and invasion and enhances chemosensitivity in esophageal squamous cell carcinoma by regulating the PI3K/AKT signaling pathwaySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.